- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Biologic Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Biologic Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Biologic Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Abbott Laboratories
Eli Lilly
Pfizer
Novartis
Amgen
Sanofi
Johnson & Johnson
Merck & Co
Roche
By Type:
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
By End-User:
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biologic Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Biologic Drugs Market Size and Growth Rate of Humira from 2016 to 2027
-
1.3.2 China Biologic Drugs Market Size and Growth Rate of Remicade from 2016 to 2027
-
1.3.3 China Biologic Drugs Market Size and Growth Rate of Rituxan from 2016 to 2027
-
1.3.4 China Biologic Drugs Market Size and Growth Rate of Enbrel from 2016 to 2027
-
1.3.5 China Biologic Drugs Market Size and Growth Rate of Lantus from 2016 to 2027
-
1.3.6 China Biologic Drugs Market Size and Growth Rate of Avastin from 2016 to 2027
-
1.3.7 China Biologic Drugs Market Size and Growth Rate of Herceptin from 2016 to 2027
-
1.3.8 China Biologic Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Biologic Drugs Market Size and Growth Rate of Diabetes from 2016 to 2027
-
1.4.2 China Biologic Drugs Market Size and Growth Rate of Inflammation from 2016 to 2027
-
1.4.3 China Biologic Drugs Market Size and Growth Rate of Auto-Immune Diseases from 2016 to 2027
-
1.4.4 China Biologic Drugs Market Size and Growth Rate of Blood Diseases from 2016 to 2027
-
1.4.5 China Biologic Drugs Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
1.4.6 China Biologic Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Biologic Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biologic Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Humira
-
3.4.2 Market Size and Growth Rate of Remicade
-
3.4.3 Market Size and Growth Rate of Rituxan
-
3.4.4 Market Size and Growth Rate of Enbrel
-
3.4.5 Market Size and Growth Rate of Lantus
-
3.4.6 Market Size and Growth Rate of Avastin
-
3.4.7 Market Size and Growth Rate of Herceptin
-
3.4.8 Market Size and Growth Rate of Others
4 Segmentation of Biologic Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biologic Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Biologic Drugs in Diabetes
-
4.4.2 Market Size and Growth Rate of Biologic Drugs in Inflammation
-
4.4.3 Market Size and Growth Rate of Biologic Drugs in Auto-Immune Diseases
-
4.4.4 Market Size and Growth Rate of Biologic Drugs in Blood Diseases
-
4.4.5 Market Size and Growth Rate of Biologic Drugs in Cardiovascular Diseases
-
4.4.6 Market Size and Growth Rate of Biologic Drugs in Others
5 Market Analysis by Regions
-
5.1 China Biologic Drugs Production Analysis by Regions
-
5.2 China Biologic Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Biologic Drugs Landscape Analysis
-
6.1 North China Biologic Drugs Landscape Analysis by Major Types
-
6.2 North China Biologic Drugs Landscape Analysis by Major End-Users
7 Central China Biologic Drugs Landscape Analysis
-
7.1 Central China Biologic Drugs Landscape Analysis by Major Types
-
7.2 Central China Biologic Drugs Landscape Analysis by Major End-Users
8 South China Biologic Drugs Landscape Analysis
-
8.1 South China Biologic Drugs Landscape Analysis by Major Types
-
8.2 South China Biologic Drugs Landscape Analysis by Major End-Users
9 East China Biologic Drugs Landscape Analysis
-
9.1 East China Biologic Drugs Landscape Analysis by Major Types
-
9.2 East China Biologic Drugs Landscape Analysis by Major End-Users
10 Northeast China Biologic Drugs Landscape Analysis
-
10.1 Northeast China Biologic Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Biologic Drugs Landscape Analysis by Major End-Users
11 Southwest China Biologic Drugs Landscape Analysis
-
11.1 Southwest China Biologic Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Biologic Drugs Landscape Analysis by Major End-Users
12 Northwest China Biologic Drugs Landscape Analysis
-
12.1 Northwest China Biologic Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Biologic Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Abbott Laboratories
-
13.1.1 Abbott Laboratories Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Eli Lilly
-
13.2.1 Eli Lilly Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Pfizer
-
13.3.1 Pfizer Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Novartis
-
13.4.1 Novartis Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Amgen
-
13.5.1 Amgen Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Sanofi
-
13.6.1 Sanofi Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Johnson & Johnson
-
13.7.1 Johnson & Johnson Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Merck & Co
-
13.8.1 Merck & Co Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Roche
-
13.9.1 Roche Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Biologic Drugs Market Size and Growth Rate of Humira from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Remicade from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Rituxan from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Enbrel from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Lantus from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Avastin from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Herceptin from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Diabetes from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Inflammation from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Auto-Immune Diseases from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Blood Diseases from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
Figure China Biologic Drugs Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Biologic Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Biologic Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Biologic Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biologic Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Biologic Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Humira
-
Figure Market Size and Growth Rate of Remicade
-
Figure Market Size and Growth Rate of Rituxan
-
Figure Market Size and Growth Rate of Enbrel
-
Figure Market Size and Growth Rate of Lantus
-
Figure Market Size and Growth Rate of Avastin
-
Figure Market Size and Growth Rate of Herceptin
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Biologic Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Biologic Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Diabetes
-
Figure Market Size and Growth Rate of Inflammation
-
Figure Market Size and Growth Rate of Auto-Immune Diseases
-
Figure Market Size and Growth Rate of Blood Diseases
-
Figure Market Size and Growth Rate of Cardiovascular Diseases
-
Figure Market Size and Growth Rate of Others
-
Table China Biologic Drugs Production by Regions
-
Table China Biologic Drugs Production Share by Regions
-
Figure China Biologic Drugs Production Share by Regions in 2016
-
Figure China Biologic Drugs Production Share by Regions in 2021
-
Figure China Biologic Drugs Production Share by Regions in 2027
-
Table China Biologic Drugs Consumption by Regions
-
Table China Biologic Drugs Consumption Share by Regions
-
Figure China Biologic Drugs Consumption Share by Regions in 2016
-
Figure China Biologic Drugs Consumption Share by Regions in 2021
-
Figure China Biologic Drugs Consumption Share by Regions in 2027
-
Table North China Biologic Drugs Consumption by Types from 2016 to 2027
-
Table North China Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Biologic Drugs Consumption Share by Types in 2016
-
Figure North China Biologic Drugs Consumption Share by Types in 2021
-
Figure North China Biologic Drugs Consumption Share by Types in 2027
-
Table North China Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Biologic Drugs Consumption Share by End-Users in 2016
-
Figure North China Biologic Drugs Consumption Share by End-Users in 2021
-
Figure North China Biologic Drugs Consumption Share by End-Users in 2027
-
Table Central China Biologic Drugs Consumption by Types from 2016 to 2027
-
Table Central China Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Biologic Drugs Consumption Share by Types in 2016
-
Figure Central China Biologic Drugs Consumption Share by Types in 2021
-
Figure Central China Biologic Drugs Consumption Share by Types in 2027
-
Table Central China Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Biologic Drugs Consumption Share by End-Users in 2016
-
Figure Central China Biologic Drugs Consumption Share by End-Users in 2021
-
Figure Central China Biologic Drugs Consumption Share by End-Users in 2027
-
Table South China Biologic Drugs Consumption by Types from 2016 to 2027
-
Table South China Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Biologic Drugs Consumption Share by Types in 2016
-
Figure South China Biologic Drugs Consumption Share by Types in 2021
-
Figure South China Biologic Drugs Consumption Share by Types in 2027
-
Table South China Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Biologic Drugs Consumption Share by End-Users in 2016
-
Figure South China Biologic Drugs Consumption Share by End-Users in 2021
-
Figure South China Biologic Drugs Consumption Share by End-Users in 2027
-
Table East China Biologic Drugs Consumption by Types from 2016 to 2027
-
Table East China Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Biologic Drugs Consumption Share by Types in 2016
-
Figure East China Biologic Drugs Consumption Share by Types in 2021
-
Figure East China Biologic Drugs Consumption Share by Types in 2027
-
Table East China Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Biologic Drugs Consumption Share by End-Users in 2016
-
Figure East China Biologic Drugs Consumption Share by End-Users in 2021
-
Figure East China Biologic Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Biologic Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Biologic Drugs Consumption Share by Types in 2016
-
Figure Northeast China Biologic Drugs Consumption Share by Types in 2021
-
Figure Northeast China Biologic Drugs Consumption Share by Types in 2027
-
Table Northeast China Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Biologic Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Biologic Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Biologic Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Biologic Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Biologic Drugs Consumption Share by Types in 2016
-
Figure Southwest China Biologic Drugs Consumption Share by Types in 2021
-
Figure Southwest China Biologic Drugs Consumption Share by Types in 2027
-
Table Southwest China Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Biologic Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Biologic Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Biologic Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Biologic Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Biologic Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Biologic Drugs Consumption Share by Types in 2016
-
Figure Northwest China Biologic Drugs Consumption Share by Types in 2021
-
Figure Northwest China Biologic Drugs Consumption Share by Types in 2027
-
Table Northwest China Biologic Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Biologic Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Biologic Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Biologic Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Biologic Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Merck & Co
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co
-
Figure Sales and Growth Rate Analysis of Merck & Co
-
Figure Revenue and Market Share Analysis of Merck & Co
-
Table Product and Service Introduction of Merck & Co
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-

Chinese